HIGHLIGHTS
- who: Piera Federico and colleagues from the Division of Medical Oncology, Department of Precision Medicine, School of Medicine, University of Study of Campania "LVanvitelli", Napoli, Italy have published the article: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives, in the Journal: Cancers 2020, x of /2020/
- what: In this review the authors provide an overview of the role of ICIs in the management of HCC with a critical evaluation of the current status and future directions. The interim data_analysis of this trial showed a response rate in 32% of patients by RECIST . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.